Story perspectives

FDA Approves New COVID Vaccines, Critics Warn of Risks

8/28/2025

Summary

FDA Vaccine Approval

The FDA approved new COVID-19 vaccines on August 27, limiting access to individuals over 65 and those with health conditions.
Emergency use authorizations were rescinded, affecting previous vaccine mandates.
Many may incur out-of-pocket costs, with uncertain health insurance coverage.
Critics raise concerns about potential public health risks stemming from these restrictions.

Summary

FDA Vaccine Restrictions

The FDA's updated COVID-19 vaccine approval restricts access to individuals over 65 and those with specific health conditions, complicating vaccination for healthy children and adults.
Revoked emergency use authorizations raise concerns about insurance coverage and out-of-pocket costs.
The American Academy of Pediatrics advocates for broader vaccine access for children under 2 years old.
Health Secretary Robert F. Kennedy Jr. assures continued vaccine availability after doctor consultations.
The CDC's advisory committee will soon discuss future vaccination recommendations.

1 of 2

FDA Vaccine Approval

The FDA approved new COVID-19 vaccines on August 27, limiting access to individuals over 65 and those with health conditions.
Emergency use authorizations were rescinded, affecting previous vaccine mandates.
Many may incur out-of-pocket costs, with uncertain health insurance coverage.
Critics raise concerns about potential public health risks stemming from these restrictions.

1 / 2